AGC Biologics begins operations at new manufacturing building in Copenhagen
The new facility uses the latest mammalian systems and single-use technology, including a production line with eight 2,000 L bioreactors
The new facility uses the latest mammalian systems and single-use technology, including a production line with eight 2,000 L bioreactors
Subscribe To Our Newsletter & Stay Updated